Acute leukaemia, Blood cancers, Leukaemia, Myelodysplastic syndrome (MDS)
Results
Phase 1/2
This trial looked at a drug called panobinostat alongside the chemotherapy drug azacitidine, for certain types of leukaemia and myelodysplastic syndromes. It was for people who couldn’t have a stem cell transplant.
Recruitment start: 2 December 2009
Recruitment end: 30 April 2013
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Dr Jamie Cavenagh
Experimental Cancer Medicines Centres (ECMC)
NIHR Clinical Research Network: Cancer
Novartis
Last reviewed: 11 Oct 2018
CRUK internal database number: 9435
About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education
What to ask your doctor about clinical trials.
Meet and chat to other cancer people affected by cancer.
Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.
